Non-Hodgkin’s Lymphoma Myrtle Beach SC

Cancer is an extremely scary and life changing disease. If you or someone you know has been diagnosed with Non-Hodgkin’s Lymphoma, read the following articles to better understand the disease and to learn helpful information such as screening techniques and different treatment options that are available.
Newest Topics

Non-Hodgkin Lymphoma in Youth Myrtle Beach SC

Non-Hodgkin’s lymphoma (NHL) is a form of cancer that begins in the cells of the lymph system. Results of researches suggest that young adults with NHL have a higher risk of death than children and teens with NHL. Read on for details.

Minimal Residual MALT Lymphoma of the Stomach Myrtle Beach SC

Watch and Wait strategy May Be Sufficient for Patients with Minimal Residual MALT Lymphoma of the Stomach. Among patients who have minimal residual MALT lymphoma of the stomach after eradication of H. pylori infection, outcomes appear to be good even without additional cancer treatment. Read more.

Veltuzumab Effective for Refractory Non-Hodgkin’s Lymphoma Myrtle Beach SC

Veltuzumab is a humanized anti-CD20 antibody that differs structurally from Rituxan® (rituximab). It is safe and effective for patients with relapsed/refractory B-cell non-Hodgkin’s lymphoma. Read on to know more about Veltuzumab and its effective for refractory non-hodgkin’s lymphoma.

Management of Aggressive Non-Hodgkin’s Lymphoma Myrtle Beach SC

This articles provides you some treatment options suggested by Dr. John Hainsworth of the Sarah Cannon Research Institute for diffuse large cell lymphoma and other aggressive non-Hodgkin’s lymphoma.

Management of Recurrent Intermediate NHL Myrtle Beach SC

This article provides you some useful information of the management of recurrent intermediate NHL. If you are concerned about this cancer, keep on reading to discover more details.

All Topics

Cell Phone and Risk of Developing Meningioma Brain Cancer Myrtle Beach SC

Meningiomas arise from cells in the meninges, the three membranes that cover the brain and spinal cord. Meningiomas comprise 24% of all primary brain tumors, making them the most common of all primary brain tumors. Although meningiomas make up a large percentage of brain tumors, they are typically slow growing and non-cancerous (benign) and thus responsible for only 7% of all deaths from brain tumors.

Central Nervous System Lymphomas Treatment Myrtle Beach SC

Lymphoma is a type of cancer that affects the body’s immune cells. Some lymphomas can originate in the central nervous system (CNS), although this is not common. These lymphomas are referred to as primary central nervous system lymphoma (PCNSL). As well, lymphomas can spread (metastasize) from the body’s lymph organs to the CNS.

Follicular Lymphoma Myrtle Beach SC

Follicular lymphoma affects the B-cells, a type of lymphoma cell. It occurs more commonly in elderly patients; the average age at diagnosis is 60 years. The majority of patients have advanced disease at the time of diagnosis, and patients commonly have cancer cells that have spread outside the lymph system.

High-dose Methotrexate Provides Long-term Results in Central Nervous System Lymphoma Myrtle Beach SC

Primary central nervous system lymphoma arises in the central nervous system (CNS). Lymphoma is a cancer that originates in immune cells called lymphocytes. Primary central nervous system lymphoma (a minority of lymphomas), however, begin in the CNS, which includes the spinal cord and brain.

Intermediate Grade/Aggressive Grade NHL Myrtle Beach SC

Intermediate grade non-Hodgkin’s lymphomas are the most common of all lymphomas, and are considered aggressive in nature. The most common is diffuse large B-cell lymphoma, which accounts for over 30% of all lymphomas. Lymphomas classified according to the REAL or IWF system are listed below.

Lymphoma Treatment Myrtle Beach SC

Lymphoma treatment fights cancer that affects the lymphatic system, which includes lymph nodes and chromosomes. Types of lymphomas are low-grade lymphomas, high-grade lymphomas, Hodgkin’s disease, and non-Hodgkin’s lymphoma. Treatment may involve radiotherapy, chemotherapy, and bone marrow transplants. Read on to learn more and to gain access to oncologists in Myrtle Beach, SC who provide lymphoma treatment.

Management of Aggressive Non-Hodgkin’s Lymphoma Myrtle Beach SC

This articles provides you some treatment options suggested by Dr. John Hainsworth of the Sarah Cannon Research Institute for diffuse large cell lymphoma and other aggressive non-Hodgkin’s lymphoma.

Management of Recurrent Intermediate NHL Myrtle Beach SC

This article provides you some useful information of the management of recurrent intermediate NHL. If you are concerned about this cancer, keep on reading to discover more details.

Minimal Residual MALT Lymphoma of the Stomach Myrtle Beach SC

Watch and Wait strategy May Be Sufficient for Patients with Minimal Residual MALT Lymphoma of the Stomach. Among patients who have minimal residual MALT lymphoma of the stomach after eradication of H. pylori infection, outcomes appear to be good even without additional cancer treatment. Read more.

Non-Hodgkin Lymphoma in Youth Myrtle Beach SC

Non-Hodgkin’s lymphoma (NHL) is a form of cancer that begins in the cells of the lymph system. Results of researches suggest that young adults with NHL have a higher risk of death than children and teens with NHL. Read on for details.

Relapsed Aggressive NHL Myrtle Beach SC

Patients with relapsed NHL are typically re-treated with chemotherapy using drugs that are different from those administered for initial treatment. High-dose chemotherapy with stem cell transplantation has been shown to produce better outcomes than re-treatment with conventional chemotherapy.

Relapsed Follicular NHL Myrtle Beach SC

Patients with follicular lymphoma have a low chance for cure with standard treatment options. Relapsed follicular lymphomas occur predominantly in elderly persons. Treatment plans are currently directed at prolonging life with minimal side effects.

Stage IIE-IV Aggressive NHL Myrtle Beach SC

Aggressive lymphomas are classified according to two systems: the Revised European American Lymphoma (REAL) system and the International Working Formulation (IWF). The following types of non-Hodgkin’s lymphoma are all considered to be intermediate or aggressive in nature and are treated similarly.

Stage IIE-IV Follicular NHL Myrtle Beach SC

Overview Stage IIE-IV follicular NHL is an advanced disease in which the cancer has invaded lymph node regions near the diaphragm (the breathing muscle separating the abdomen from the chest) and may have spread to organs outside the lymph system. The majority of patients diagnosed with follicular lymphoma have grade III-IV disease.

Stage I-II Aggressive NHL Myrtle Beach SC

Patients classified as having stage I, IE, or IIA non-Hodgkin’s lymphoma (NHL) are considered to have localized disease. More than half of these patients can be cured with initial treatment.

Stage I-II Follicular NHL Myrtle Beach SC

Follicular lymphoma is a slow growing cancer, which means that patients may survive for a long time without treatment. The major dilemmas regarding treatment of follicular lymphomas are when to initiate treatment and whether more aggressive treatments can improve a patient’s outcome compared to treatment with radiation therapy alone.

Understanding Indolent or Follicular Lymphoma Myrtle Beach SC

Dr. John Hainsworth of the Sarah Cannon Research Institute discusses the treatment of follicular or indolent non-Hodgkin’s lymphoma.

Understanding Non-Hodgkin’s Lymphoma Myrtle Beach SC

Dr. John Hainsworth of the Sarah Cannon Research Institute explains the different types of non-Hodgkin’s lymphoma. Read on to know more about non-Hodgkin's lymphoma.

Veltuzumab Effective for Refractory Non-Hodgkin’s Lymphoma Myrtle Beach SC

Veltuzumab is a humanized anti-CD20 antibody that differs structurally from Rituxan® (rituximab). It is safe and effective for patients with relapsed/refractory B-cell non-Hodgkin’s lymphoma. Read on to know more about Veltuzumab and its effective for refractory non-hodgkin’s lymphoma.